In Other News

• Blood Biomarker May Predict Colitis Risk in Checkpoint Inhibitor Therapy

• Noninvasive Imaging Approach Aims to Detect Basal Cell Carcinoma Before It Becomes Visible

• Multi-Cancer Blood Test Expands Detection to Cancers Lacking Routine Screening Options

• Liquid Biopsy Shows Promise for Detecting and Monitoring Malignant Nerve Sheath Tumors

• Early-Life Gut Microbiome Changes May Help Assess Type 1 Diabetes Risk

• Expanded Newborn Screening Program Increases Detection of Congenital Cytomegalovirus

• FDA Breakthrough-Designated Urine Panel Aims to Shorten Pathogen and Susceptibility Testing

• Genetic Studies Uncover Mechanisms Driving Drug Resistance in Superbugs

• Blood-Based MRD Test Predicts Recurrence Risk After Lung Cancer Surgery

• Siemens Healthineers and Novo Collaborate to Expand Access to Noninvasive Liver Testing

• Early-Life Gut Microbiome Changes May Help Assess Type 1 Diabetes Risk

• Blood Test Could Guide Drug Selection to Prevent Repeat Heart Attacks and Strokes

• Multiomic Blood Test Supports Noninvasive Monitoring and Subtyping in Pancreatic Cancer

• Electronic Genome Mapping Reveals Structural Abnormalities in Hematologic Malignancies

• Tumor Blood Vessel Features May Help Predict Colorectal Cancer Survival

• Multimodal AI Improves Breast Cancer Recurrence Risk Prediction Beyond Standard Genomic Testing

• Rare Genetic Variant Linked to Dramatically Higher Lung Cancer Risk

• Mayo Clinic and Thermo Fisher Launch Multi-Omics Venture to Identify Early Disease Signals

• Sputum-Based Lung Cancer Test Technology Granted Hong Kong Patent

• Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

• Multimodal AI Improves Treatment Response Prediction in Lung Cancer

• Blood Test Patterns Improve Cancer Risk Assessment in Primary Care

• Machine Learning Cytology Tool Improves Cancer Cell Identification